Beta-adrenergic signaling promotes tumor angiogenesis and prostate cancer progression through HDAC2-mediated suppression of thrombospondin-1
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Beta-adrenergic signaling promotes tumor angiogenesis and prostate cancer progression through HDAC2-mediated suppression of thrombospondin-1
Authors
Keywords
-
Journal
ONCOGENE
Volume 36, Issue 11, Pages 1525-1536
Publisher
Springer Nature
Online
2016-09-19
DOI
10.1038/onc.2016.319
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Integrative Clinical Genomics of Advanced Prostate Cancer
- (2015) Dan Robinson et al. CELL
- The Molecular Taxonomy of Primary Prostate Cancer
- (2015) Adam Abeshouse et al. CELL
- CDKL2 promotes epithelial-mesenchymal transition and breast cancer progression
- (2015) Linna Li et al. Oncotarget
- New and emerging HDAC inhibitors for cancer treatment
- (2014) Alison C. West et al. JOURNAL OF CLINICAL INVESTIGATION
- Quantitative assessment of angiogenesis, perfused blood vessels and endothelial tip cells in the postnatal mouse brain
- (2014) Thomas Wälchli et al. Nature Protocols
- GRK3 is essential for metastatic cells and promotes prostate tumor progression
- (2014) W. Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Improved survival outcomes with the incidental use of beta-blockers among patients with non-small-cell lung cancer treated with definitive radiation therapy
- (2013) H. M. Wang et al. ANNALS OF ONCOLOGY
- Antihypertensive medications and survival in patients with cancer: A population-based retrospective cohort study
- (2013) Signy Holmes et al. Cancer Epidemiology
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- Neuroendocrine influences on cancer progression
- (2012) Guillermo N. Armaiz-Pena et al. BRAIN BEHAVIOR AND IMMUNITY
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
- (2012) Jordi Barretina et al. NATURE
- Use of β-blockers is associated with prostate cancer-specific survival in prostate cancer patients on androgen deprivation therapy
- (2012) Helene Hartvedt Grytli et al. PROSTATE
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- Valproic acid decreases urothelial cancer cell proliferation and induces thrombospondin-1 expression
- (2012) Timothy K Byler et al. BMC Urology
- Beta Blockers and Breast Cancer Mortality: A Population- Based Study
- (2011) Thomas I. Barron et al. JOURNAL OF CLINICAL ONCOLOGY
- Thrombospondin-1 induces platelet activation through CD36-dependent inhibition of the cAMP/protein kinase A signaling cascade
- (2010) W. Roberts et al. BLOOD
- In vitro angiogenesis: endothelial cell tube formation on gelled basement membrane extract
- (2010) Irina Arnaoutova et al. Nature Protocols
- Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy
- (2010) Julia M. Wagner et al. Clinical Epigenetics
- Recruitment of cAMP-response Element-binding Protein and Histone Deacetylase Has Opposite Effects on Glucocorticoid Receptor Gene Transcription
- (2009) Manjapra Variath Govindan JOURNAL OF BIOLOGICAL CHEMISTRY
- Depression and Coronary Heart Disease
- (2008) Judith H. Lichtman et al. CIRCULATION
- Selective Structure-Based Virtual Screening for Full and Partial Agonists of the β2 Adrenergic Receptor
- (2008) Chris de Graaf et al. JOURNAL OF MEDICINAL CHEMISTRY
- Angiogenesis selectively requires the p110α isoform of PI3K to control endothelial cell migration
- (2008) Mariona Graupera et al. NATURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now